Aldosterone induces clonal β-cell failure through glucocorticoid receptor

Area of Science:

• Endocrinology
• Molecular Biology
• Metabolic Diseases

Background:

• Aldosterone excess is linked to insulin resistance in peripheral tissues.
• Aldosterone directly impairs pancreatic beta-cell function, contributing to metabolic dysfunction.
• The precise molecular mechanisms underlying aldosterone's detrimental effects on beta-cells require elucidation.

Purpose of the Study:

• To investigate the molecular pathways through which aldosterone excess impairs clonal beta-cell function.
• To determine the roles of Glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) in aldosterone-induced beta-cell dysfunction.
• To identify key signaling molecules and transcription factors involved in aldosterone's effects on beta-cells.

Main Methods:

• Utilized clonal beta-cells exposed to aldosterone.
• Employed Glucocorticoid receptor (GR) antagonists and specific siRNA.
• Assessed apoptosis, insulin synthesis/secretion, MafA expression/activity, and MAPK pathway activation (JNK, p38).
• Used specific inhibitors for JNK and p38, and performed gene overexpression studies.

Main Results:

• Aldosterone induced beta-cell apoptosis and dysfunction, impairing insulin synthesis and secretion.
• These effects were reversed by GR antagonists but not MR antagonists.
• Aldosterone decreased MafA expression/activity and activated JNK/p38 MAPK via GR.
• JNK/p38 inhibition or MafA overexpression protected against aldosterone-induced beta-cell damage.

Conclusions:

• Aldosterone excess impairs clonal beta-cell function and survival through a Glucocorticoid receptor (GR)-dependent pathway.
• The GR-MAPK-MafA signaling axis is critical in mediating aldosterone's detrimental effects on beta-cells.
• Targeting this pathway may offer therapeutic strategies for managing aldosterone-induced beta-cell failure and associated metabolic complications.